Related to this topic: Leaflets | Support | Patient+ | News | Weblinks | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Myopathies

Description

Myopathies are a heterogeneous group of conditions affecting muscle usually without involvement of the nervous system and independent of any disorder of the neuromuscular junction. They have a diverse aetiology. The muscular dystrophies are the most common of such disorders and Duchenne muscular dystrophy (DMD) is the most common muscular dystophy. However the broad range of myopathies is outilned in the boxes below which include some of the rare primary disorders of muscle as well as acquired myopathies. The subsequent sections put these conditions in context and highlight some contrasting diagnostic and clinical features. Most of the congenital myopathies are chronic and slowly progressive. However, metabolic, inflammatory, toxic and endocrine myopathies present subacutely or even acutely and this requires awareness amongst front line physicians to recognise and diagnose myopathy.

Classification

The primary myopathies1,2,3,4

The primary myopathies

  • Muscular dystrophies- disorders of dystrophin:
    • Duchenne muscular dystrophy (DMD) including Becker muscular dystrophy- DMD is the most common childhood-onset muscular dystrophy (1 in 3,500 or 63 per million boys) and Becker (24 per million)
    • Fascioscapulohumeral muscular dystrophy
    • Limb girdle muscular dystropy
    • Emery-Dreifuss muscular dystrophy
    • Rare forms of muscular dystrophy including:
      • Distal muscular dystrophy
      • Oculopharyngeal muscular dystrophy
      • Congenital muscular dystrophy (CMD)- caused by genetic mutations and generally autosomal recessive disorders (prevalence approximately 5 per 100,000):
        • Extracellular matrix protein defects:
          • Laminin-alpha 2 deficiency
          • Ullrich CMD.
        • Integrin-alpha7 deficiency
        • Glycosyltransferases:
          • Walker-Warburg syndrome
          • Muscle-eye-brain disease (MEB)
          • Fukuyama CMD- quite common in Japan (7-12 per 100,000)
          • CMD with laminin deficiency (2 types)
          • CMD with mental retardation.
        • Proteins of the endoplasmic reticulum:
          • Rigid-spine syndrome.
  • Congenital myopathies-these are rare (unknown incidence) conditions in which gene defects lead to muscle protein defects:
    • Nemaline rod myopathy
    • Central core disease
    • Centronuclear myopathy
    • Minimulticore myopathy
    • Type 1 fibre predominance.
  • Metabolic myopathies:
    • Hereditary muscle disorders caused by enzymatic defects (usually considered to be inborn errors of metabolism affecting the 3 major pathways of ATP supply) and relatively rare (much less common than the muscular dystrophies):
      • Gycogen storage diseases
      • Lipid storage disease
        • Carnitine palmitoyltransferase deficiency- (Relative deficiency identified in as many as 1 in 150 patients)
        • Myopathic carnitine deficiency.
      • Disorders of purine nucleotide metabolism (affects replenishment of ATP)
      • Mitochondrial disorders.

The acquired myopathies

The acquired myopathies
  • Secondary metabolic and endocrine myopathies:
    • Thyroid disease:
    • Parathyroid dysfunction:
    • Pituitary dysfunction (for example Addison disease)- myopathy through either adrenal dysfunction or secondary thyroid dysfunction.
    • Corticosteroids:
      • Cushing disease
      • Exogenous steroids- especially high doses (over 25mg per day).
    • Biochemical:
      • Hypokalaemia and hyperkalaemia can cause muscle weakness and myotonia (stiffness)
      • May be caused by varieties of acute periodic paralysis (genetic)
      • Secondary to acute gastrointestinal loss
      • Secondary to endocrine disease
      • Renal disease
      • Excessive liquorice ingestion.
    • Diabtetes mellitus.
  • Dermatomyositis and polymyositis-these are inflammatory myopathies (possible autoimmune basis) with weakness, endomysial inflammation and elevated muscle enzymes:
    • Primary polymyositis (idiopathic adult)
    • Dermatomyositis (idiopathic adult)
    • Childhood dermatomyositis (or myositis with necrotising vasculitis)
    • Polymyositis associated with connective tissue disorder
    • Polymyositis or dermatomyositis associated with neoplasia.
  • Drug induced myopathy:
  • Infectious causes:
  • Polymyalgia rheumatica:
    • Proximal myopathy with associated muscle tenderness.
  • Epidemiology

    These are all relatively uncommon diseases. DMD has the highest prevalence of the myopathies.

    Presentation

    Clinical features of myopathy

    Clinical features of myopathy:

    • The hallmark symptom of myopathy (and neuromuscular disease) is weakness
    • Weakness predominantly affecting proximal muscle groups (shoulder and limb girdles) is typical
    • Weakness manifests itself in different ways at different ages:
      • Decreased foetal movements movements in utero
      • Floppy infant neonatally
      • Motor delay in the toddler years
      • Reduced muscle strength and power in older children and adults.
    • Myalgia may occur in inflammatory myopathies
    • Muscle-stretch reflexes are preserved
    • Somatosensory reflexes are preserved
    • Variation of strength with exercise (either increasing or decreasing) can occur:
      • Fluctuating muscle power suggests metabolic myopathy (for example McArdle disease)
      • Fatigability (or progressive weakness with exertion relieved by rest) is a feature of myasthenia gravis where the defect is in neuromuscular transmission.

    History

    • Common symptoms:
      • Symmetrical proximal muscle weakness
      • Malaise
      • Fatigue
      • Absence of sensory symptoms (paraesthesia)
      • Atrophy of muscles (and reduced reflexes) occurs late with myopathies (early with neuropathy)
      • Waddling gait of DMD at age 3-6 years is typical.
    • How acute are the symptoms?
      • Weakness over hours suggests toxic cause or episodic paralysis
      • Weakness developing over days- consider dermatomyositis or rhabdomyolysis
      • Weakness over weeks suggests polymyositis, steroid myopathy, endocrine myopathy.
    • Pain and tenderness without weakness- consider other causes
    • Which muscle groups are affected?
      • Proximal muscle groups- difficulty rising from chair, climbing stairs, shaving, hair combing
      • Distal muscles- difficulty walking (flaping gait), grasping, handwriting.
    • Metabolic myopathies present with:
      • Difficulty with exercise
      • Cramps and myalgia with exercise (early with glycogen storage disorders and after prolonged exercise with lipid storage disorders)
      • Myoglobinuria
      • Progressive muscle weakness in some metabolic myopathies.
    • Past medical history:
    • Family history:
      • Muscular dystrophy
      • Other relevant conditions or myopathies.
    • Medication:
      • Steroids
      • Lipid lowering drugs
      • Alcohol
      • Colchicine
      • Heroin
      • Azidothymidine.
    • Occupational history:
      • Pottery industry-glazing salts can cause hypokalaemic paralysis.

    Examination

    • Symmetrical proximal muscle weakness
    • Muscle tenderness very rare with myopathy
    • Fever with inflammatory causes
    • There is usually no wasting but there may be hypertrophy of muscle (atrophy is a late sign)
    • Reflexes and sensation usually normal
    • Hypotonia is common in some myopathies (for example congenital myopathies)
    • There may be helpful additional signs such as the skin changes of dermatomyositis
    • Urine should be examined- myoglobinuria in acute alcoholic myopathy can cause renal tubular necrosis.
    Differential Diagnosis

    This list includes other conditions causing weakness:

    • It may be difficult to distinguish myopathy from peripheral neuropathy. The distinguishing clinical features of peripheral neuropathy are:
      • Weakness affects distal muscles- although there are exceptions:
      • Reduced muscle- stretch reflexes
      • Fasciculations
      • Somatosensory abnormalities.
    • Some complex cases may have both neurogenic and myopathic disorders which can lead to diagnostic confusion:
      • Diabetes mellitus can cause both neuropathy and inflammatory myopathy
      • Cancer can cause dermatomyositis and chemotherapy peripheral neuropathy in the same patient
      • Radiculopathy (from degenerative disc disease) can occur in patients with myopathy.
    Investigations

    Blood and urine tests

    These together with ECG examination are most useful in acute situations.

    • Creatinine kinase (with isoenzymes)
    • Electrolytes including calcium and magnesium
    • Serum myoglobin
    • Urea and serum creatinine
    • Urinalysis and urine microscopy- myoglobinuria inferred by positive urinalysis with few red cells at microscopy
    • Full blood count
    • ESR
    • Thyroid function tests
    • Antinuclear antibodies.

    ECG

    May show:

    • Changes of hypokalaemia- increased P-R interval, U waves, wide QRS and nonspecific ST-T changes
    • Sinus arrhthmias, deep Q waves and elevated R waves precordially (for example in DMD).

    Muscle biopsy

    Muscle biopsy is important in diagnosis but findings under the microscope are rarely pathognomonic. Interpretation requires close consideration of the clinical history in conjunction with the microscopic featues to make a diagnosis.

    Electromyography

    • Excludes primarily neurogenic processes (for example spinal muscular atropy)
    • Proximal muscles of lower extremeties often exhibit most prominent features
    • Often helps to confirm diagnosis but not in itself diagnostic.

    MRI

    • May help exclude neurological disease
    • May help in assessing complications (musculoskeletal or involving other organs).

    Genetic testing

    The genetic basis of the primary myopathies means that genetic testing can be essential to the specific diagnosis.

    Management

    This depends on the diagnosis as well as the severity and extent of disease.

    Emergency manangement

    Myopathy can, rarely, present acutely or with acute complications. Examples include:

    • Respiratory difficulties:
      • Respiratory failure can occur in a number of the myopathies
      • Aspiration pneumonia may be associated with this
      • Cardiac complications may be associated including cardiomyopathy and conduction defects.
    • Some metabolic myopathies:
      • Hypokalaemia:
      • Hyperkalaemia:
        • Carbohydrate loading (for example early in attacks with hyperkalaemic periodic paralysis)
        • Glucose and insulin.
      :
    • Rhabdomyolysis:
      • Causes life threatening renal complications and associated metabolic problems (hyperkalaemia)
      • Usually requires intensive care management.
    • Polymyalgia rheumatica:

    Long term care

    • Myopathy associated with respiratory failure:
      • Monitor pulmonary function (early restrictive pattern may occur before onset of symptoms)
      • Beware of symptoms of nocturnal hypoxia (poor sleep, nightmares, headaches)
      • Physiotherapy
      • May require tracheostomy and permanent ventilation.
    • Specific medication may be useful in particular situations for particular myopathies
    • Genetic counselling
    • Surgery:
      • Tendon release surgery for example to prolong ability to walk.
    • Physical aids:
    • Family support
    • Dietary advice
      • General- for example to prevent obesity
      • Specific.
    Complications
    • Respiratory failure
    • Aspirartion pneumonia
    • Musculoskeletal problems:
      • Many associated deformities can occur
      • Joint contractures
      • Chest deformities
      • Spinal deformities including scoliosis.
    • Malignant hyperthermia can occur with central core disease.
    Prognosis

    This depends on the specific diagnosis. The primary disorders are incurable conditions with varied prognosis. Secondary myopathy may be corrected by treating the underlying cause.

    Prevention

    Genetic counselling is, in some of the most common myopathies such as DMD, the only intervention that can prevent disease. In general:

    • Give genetic counseling early
    • Test early for carrier status where appropriate
    • Consider prenatal diagnostic testing where appropriate
    • Advances in molecular genetics may help in the future.

    Document References
    1. Mellion M; Dystrophinopathies; eMedicine (2006)
    2. Lopate G; Congenital Muscular Dystrophy; eMedicine (2007)
    3. Lopate G; Congenital Myopathies; eMedicine (2007)
    4. Katiriji B; Metabolic Myopathies; eMedicine (2007)
    Acknowledgements EMIS is grateful to Dr Richard Draper for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
    DocID: 1703
    Document Version: 20
    DocRef: bgp804
    Last Updated: 26 Mar 2007
    Review Date: 25 Mar 2009






















    Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

    Advertise on this site










    Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

    Advertise on this site


    PS - Health and Poverty

    Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

    See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

    ^ Top of Page